Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 3

1(12.5%)

Phase 2

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(5)

Phase 3(1)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07252453Not ApplicableActive Not Recruiting

Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia

Role: lead

NCT01602029Phase 2Completed

Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

Role: collaborator

NCT02703363Phase 3Completed

Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression

Role: collaborator

NCT02202694Not ApplicableCompleted

Culturally Adapted Cognitive Behavior Therapy for Psychosis in Pakistan

Role: collaborator

NCT02210390Not ApplicableCompleted

Culturally Adapted Psychological Intervention for Bipolar Disorder in Pakistan

Role: collaborator

NCT02074319Phase 1Completed

RCT of Methotrexate Added to Treatment As Usual in Schizophrenia

Role: collaborator

NCT02167347Not ApplicableCompleted

Culturally Adapted Family Intervention For Psychosis

Role: collaborator

NCT01308151Not ApplicableCompleted

Culturally Adapted Cognitive Behavioral Therapy for Prevention of Self Harm

Role: collaborator

All 8 trials loaded